| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,120 |
14,472 |
$1.88M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,996 |
17,228 |
$1.56M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,705 |
6,133 |
$656K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,846 |
4,601 |
$514K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,479 |
4,212 |
$470K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,482 |
2,270 |
$316K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,239 |
2,098 |
$255K |
| 90686 |
|
9,823 |
9,075 |
$216K |
| D1206 |
Topical application of fluoride varnish |
6,616 |
4,567 |
$164K |
| 92552 |
|
5,935 |
5,650 |
$145K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,977 |
1,937 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,014 |
4,407 |
$58K |
| 99460 |
|
661 |
599 |
$55K |
| 90698 |
|
1,979 |
1,901 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,952 |
4,483 |
$33K |
| 96127 |
|
6,737 |
6,210 |
$30K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
435 |
398 |
$29K |
| 90670 |
|
1,177 |
1,130 |
$26K |
| 87428 |
|
670 |
638 |
$25K |
| W7010 |
|
1,535 |
1,445 |
$24K |
| 0071A |
|
436 |
424 |
$17K |
| 0072A |
|
417 |
410 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
351 |
299 |
$15K |
| 90671 |
|
637 |
607 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,609 |
527 |
$13K |
| 90680 |
|
561 |
541 |
$13K |
| 90656 |
|
536 |
513 |
$12K |
| 99177 |
|
2,421 |
2,261 |
$11K |
| 90661 |
|
420 |
403 |
$9K |
| 0001A |
|
210 |
201 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
748 |
712 |
$8K |
| 97802 |
|
102 |
85 |
$7K |
| 0002A |
|
167 |
167 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
268 |
263 |
$6K |
| 97803 |
|
247 |
176 |
$6K |
| 99173 |
|
2,170 |
2,110 |
$5K |
| 96160 |
|
1,900 |
1,745 |
$5K |
| 96161 |
|
1,874 |
1,746 |
$5K |
| 90480 |
|
142 |
134 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
102 |
95 |
$5K |
| 90716 |
|
203 |
199 |
$5K |
| 90744 |
|
140 |
134 |
$3K |
| 87081 |
|
839 |
648 |
$3K |
| 90651 |
|
113 |
110 |
$3K |
| 90633 |
|
120 |
118 |
$3K |
| 99051 |
|
313 |
296 |
$2K |
| 83655 |
|
177 |
158 |
$2K |
| 90707 |
|
75 |
71 |
$2K |
| 0074A |
|
28 |
28 |
$1K |
| 36416 |
|
4,279 |
2,894 |
$793.00 |
| 90621 |
|
25 |
25 |
$743.66 |
| 90734 |
|
27 |
27 |
$628.56 |
| 99050 |
|
54 |
37 |
$412.52 |
| 90715 |
|
12 |
12 |
$279.36 |
| 83718 |
|
32 |
30 |
$214.35 |
| 82465 |
|
32 |
30 |
$113.71 |
| 82948 |
|
13 |
12 |
$52.23 |
| 99072 |
|
637 |
576 |
$37.50 |
| 99000 |
|
555 |
522 |
$2.67 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,076 |
2,790 |
$0.00 |